Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07500623 · ClinicalTrials.gov registry record · NA
Efficacy and Tolerability of a Scalp Serum
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT07500623 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 57 participants.
The verdict
NCT07500623, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the efficacy and tolerability of a scalp serum on 60 healthy females aged 25 to 65 years with Fitzpatrick skin phototypes I-VI and with mild to moderate thinning hair. The primary objective is to evaluate if the scalp serum can achieve fuller and thicker hair with fewer signs of hair shedding from baseline. The second objective is to evaluate if the scalp serum enhances scalp health including optimizing the pH and supporting microbiome at Week 4 and Week 12 compared to baseline (post-washout period). Subjects will apply a scalp serum once-daily to wet or dry hair in either the morning or evening for 12 weeks. Prospective Candidates will attend a Pre-Study Visit (PSV) at the lab to be consented. After being accepted onto the study, Volunteers will be told to stop the use of all products on their scalp and hair (shampoo, conditioner, oils, dyes etc.) other than the Sponsor-provided Ancillary Products (APs) and their regularly used, non-medicated styling products for the seven (7) days prior to Visit 1/Baseline (V1/BL) and for the duration of the study. Subjects will return to clinic for study visits at weeks 4, 8, and 12.
Interventions
- OTHER Scalp Serum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2024-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07500623
The ClinicalTrials.gov registry entry for NCT07500623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Scalp Serum is the first listed.
NCT07500623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07500623 about?
NCT07500623 is a clinical study titled "Efficacy and Tolerability of a Scalp Serum". The goal of this clinical trial is to evaluate the efficacy and tolerability of a scalp serum on 60 healthy females aged 25 to 65 years with Fitzpatrick skin phototypes I-VI and with mild to moderate thinning hair. The primary objective is to evaluate if the scalp serum can achieve fuller and thicke...
What is the current status of trial NCT07500623?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2024-02-19. Estimated completion is 2024-05-20.
What interventions are being tested in trial NCT07500623?
The interventions under investigation include: Scalp Serum (OTHER).
Who is sponsoring clinical trial NCT07500623?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.